“…Furthermore, some studies showed that miR-142, miR-155, miR-223, miR-150 and miR-144 are highly specific for hematopoietic cell lineage [21]. A differential expression of miRNAs has been shown in patients with acute rejection [23,25,29,30], interstitial fibrosis [31,32], operationally tolerant patients [33], and chronic antibody mediated rejection [24]. To our knowledge, until now miR-142-3p and miR-155 expression analysis in the blood of patients with acute T-cell mediated rejection has not been performed yet.…”